Intelligence Feed event · Equity · 2026-09-15

    Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award

    Question

    Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award

    Direct answer

    Healthcare data analytics provider Health Catalyst announced the immediate appointment of Simeon Kohl as CEO and President. The transition marks a strategic pivot for the micro-cap software provider as hospital systems seek cost efficiency and clinical decision support. To secure Kohl's employment, the company granted 2,747,385 RSUs outside of its standard shareholder-approved equity plan pursuant to Nasdaq Listing Rule 5635(c)(4), structuring retention around a two-year vesting schedule.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-15
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award”, revision 1, evidence through 2026-09-15. https://marketontology.com/market-events/2026-09-15/health-catalyst-appoints-simeon-kohl-as-ceo-with-2-75m-share-inducement-award-863ef3

    EQUITY
    Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award
    Healthcare data analytics provider Health Catalyst announced the immediate appointment of Simeon Kohl as CEO and President. The transition marks a strategic pivot for the micro-cap software provider as hospital systems seek cost efficiency and clinical decision support. To secure Kohl's employment, the company granted 2,747,385 RSUs outside of its standard shareholder-approved equity plan pursuant to Nasdaq Listing Rule 5635(c)(4), structuring retention around a two-year vesting schedule.
    HCAT
    Impact
    59
    SEP 15
    SIG
    92%
    HCAT
    Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award
    Healthcare data analytics provider Health Catalyst announced the immediate appointment of Simeon Kohl as CEO and President. The transition marks a strategic pivot for the micro-cap software provider as hospital systems seek cost efficiency and clinical decision support. To secure Kohl's employment, the company granted 2,747,385 RSUs outside of its standard shareholder-approved equity plan pursuant to Nasdaq Listing Rule 5635(c)(4), structuring retention around a two-year vesting schedule.
    → Executive leadership change accompanied by a 2.75M share equity inducement restructures governance incentives for HCAT enterprise healthcare data analytics.
    Impact
    Healthcare data analytics provider Health Catalyst announced the immediate appointment of Simeon Kohl as CEO and President. The transition marks a strategic pivot for the micro-cap software provider as hospital systems seek cost efficiency and clinical decision support. To secure Kohl's employment, the company granted 2,747,385 RSUs outside of its standard shareholder-approved equity plan pursuant to Nasdaq Listing Rule 5635(c)(4), structuring retention around a two-year vesting schedule.
    Affected
    HCAT
    Transmission
    Executive leadership change accompanied by a 2.75M share equity inducement restructures governance incentives for HCAT enterprise healthcare data analytics.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    HCATleadership transition and future share dilution from 2.75M RSU grantWatch1-5dSimeon Kohl named CEO and President with 2,747,385 RSUs granted as inducement.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month